<DOC>
	<DOCNO>NCT00051363</DOCNO>
	<brief_summary>The purpose study determine effectiveness nasal continuous positive airway pressure ( CPAP ) therapy treatment obstructive sleep apnea syndrome ( OSAS ) .</brief_summary>
	<brief_title>Apnea Positive Pressure Long-Term Efficacy Study</brief_title>
	<detailed_description>BACKGROUND : Nasal CPAP therapy widespread use primary treatment OSAS , sleep-related breathing disorder affect 15 million Americans . The therapeutic effectiveness CPAP provide significant , stable , long-term neurocognitive functional benefit patient OSAS systematically investigate . DESIGN NARRATIVE : The study randomize , blind , sham-controlled , multi-center trial CPAP therapy . The principal aim study : 1 ) ass long-term effectiveness CPAP therapy neurocognitive function , mood , sleepiness , quality life administer test index subject randomly assign active sham CPAP ; 2 ) identify specific neurocognitive deficit associate OSAS large , heterogeneous subject population ; 3 ) determine deficit neurocognitive function OSAS subject reversible sensitive effect CPAP ; 4 ) develop composite multivariate outcome measure result study used assess clinical effectiveness CPAP improve neurocognitive function , mood , sleepiness , quality life ; 5 ) use functional magnetic resonance image compare cortical activation CPAP therapy , ass whether change associate improvement specific neurocognitive task performance . The primary endpoint study effect six month CPAP treatment neurocognitive function . A total 1100 subject ( 550 per treatment group ) enrol patient population five site ( Stanford University ; University Arizona ; Brigham Women 's Hospital ; Massachusetts ; St. Luke 's Hospital , Missouri ; St. Mary Medical Center , Washington ) .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<criteria>Male female adult age 18 year old diagnosis OSAS use clinical criterion define study protocol Study participation may require seven laboratory visit six month Prior treatment OSAS continuous positive airway pressure surgery Potential sleep apnea complication may affect health safety participant , include low blood oxygen , recent nearmiss prior automobile accident due sleepiness , congestive heart failure , history angina , coronary artery disease , myocardial infarction stroke , cardiac rhythm disturbance , chronic neurological disorder affect neurocognitive ability daily function The use hypnotic , anxiolytic , sedate antidepressant , anticonvulsant , sedate antihistamine , stimulant medication likely affect neurocognitive function and/or alertness Respiratory disease require medication ( unless stable medication 2 month ) Cancer , unless remission great one year take exclusionary medication Selfreported renal failure Pregnancy anytime subject 's participation Psychiatric illness , define DSMIV diagnosis , except depression mild anxiety Narcolepsy , idiopathic hypersomnolence , DSMIV chronic insomnia , restless legs syndrome , rapid eye movement ( REM ) behavior disorder Current use diurnal nocturnal supplemental oxygen Significant vision , hearing , coordination problem Difficulty understand speak English Currently work night rotate shift Consumption 10 caffeinated beverage per day ( approximately 1,000 mg per day ) Smokers whose habit interfere overnight polysomnogram battery test day Consumption 2 alcoholic beverage per day Any illicit drug usage marijuana usage week Any individual household currently CPAP CPAP past A score 26 less Mini Mental State Examination ( MMSE )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Obstructive Sleep Apnea</keyword>
</DOC>